Rafat Sultana Ahmed

Rafat Sultana Ahmed

Auto-generated profile, based on publicly available information

Rafat Sultana Ahmed

Director Professor, Department of Biochemistry, University College of Medical Sciences and GTB Hospital, University of Delhi, New Delhi, India

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
MKMahmood Ahmad Khan
Mahmood Ahmad Khan
ASAbu Hasnath Md. Golam Sarwar
Abu Hasnath Md. Golam Sarwar
RRRani Rahat
Rani Rahat
RARafat Sultana Ahmed
Rafat Sultana Ahmed
Sadiq UmarSadiq Umar
Sadiq Umar

20 June 2008 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
RARafat S. Ahmed
Rafat S. Ahmed
SSSanvidhan G. Suke
Sanvidhan G. Suke
VSVandana Seth
Vandana Seth
ACAyanabha Chakraborti
Ayanabha Chakraborti
ATAshok K. Tripathi
Ashok K. Tripathi
BBBasu D. Banerjee
Basu D. Banerjee

18 March 2015 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Closed access
MKMahmood Ahmad Khan
Mahmood Ahmad Khan
MSMythily Subramaneyaan
Mythily Subramaneyaan
VAVinod Kumar Arora
Vinod Kumar Arora
BBBasu Dev Banerjee
Basu Dev Banerjee
RARafat Sultana Ahmed
Rafat Sultana Ahmed
Background : Rheumatoid arthritis is an inflammatory autoimmune disorder. Withania somnifera Dunal (Solanaceae) (WS), is a common medicinal plant used in traditional systems of medicine for the treatment of arthritis, and is an ingredient of anti-arthritic polyherbal formulations such as Habb-e-Asgand ® and Arthritin™. In the present study, we evaluated the antioxidant and anti-arthritic activity of aqueous extract of WS root (WSAq) in collagen-induced arthritic (CIA) rats. Methods : CIA rats were treated by using three doses of WSAq (100, 200, 300 mg/kg b. wt., orally) and methotrexate (MTX, 0.25 mg/kg b. wt. i.p.) as a standard reference drug for 20 days. The anti-arthritic effect was assayed by measuring the arthritic index, autoantibodies such as rheumatoid factor (RF), anti-cyclic citrullinated peptide antibody (a-CCP), anti-nuclear antibody (ANA), anti-collagen type II antibody (a-CII) and inflammatory marker like C-reactive protein (CRP). The oxidative stress parameters were also measured. Results : Treatment with WSAq resulted in a dose-dependent reduction in arthritic index, autoantibodies and CRP (p<0.05) with maximum effect at dose of 300 mg/kg b. wt. and the results were comparable to that of MTX-treated rats. Similarly, oxidative stress in CIA rats was ameliorated by treatment with different doses of WSAq, as evidenced by a decrease in lipid peroxidation and glutathione- S -transferase activity and an increase in the glutathione content and ferric-reducing ability of plasma (p<0.05). Conclusions : The results showed that WSAq exhibited antioxidant and anti-arthritic activity and reduced inflammation in CIA rats and suggests the potential use of this plant in the treatment of arthritis.

18 October 2010 in Renal Failure
Verified
Journal Article
Closed access
PDF file
SDSudip K. Datta
Sudip K. Datta
VKVivek Kumar
Vivek Kumar
RPRahul Pathak
Rahul Pathak
ATAshok K. Tripathi
Ashok K. Tripathi
RARafat S. Ahmed
Rafat S. Ahmed
BBBasu D. Banerjee
Basu D. Banerjee
Background and Objective: Glutathione S-transferases (GSTs) belong to a family of ubiquitous and multifunctional enzymes that work as one of the endogenous antioxidants in our body. This study was designed to look into the association of GST polymorphism with oxidative stress in both diabetic and nondiabetic chronic kidney disease (CKD). Design and Methods: Three groups of patients (50 in each): diabetics without CKD (DM), diabetic CKD (DM-CKD), and nondiabetic CKD (NDM-CKD) and 50 age- and sex-matched healthy controls were recruited. Genotyping was done for GSTM1 and GSTT1 genes using a multiplex polymerase chain reaction. Serum GST and malondialdehyde (MDA) as a marker of oxidative stress were measured spectrophotometrically. Results: Based on genotyping, subjects were categorized as GSTM1+/GSTT1+, GSTM1−/GSTT1+, GSTM1+/GSTT1−, and GSTM1−/GSTT1−. Serum GST levels were lower among subjects with deletion in one/both GST genes, whereas MDA levels were found to be correspondingly raised. A negative correlation for MDA versus GST levels was observed among genotypes with one/both gene deletions. Presence of GSTM1+/GSTT1− and GSTM1−/GSTT1− was significantly higher among patients with CKD in both diabetics and nondiabetics. Interpretations and Conclusions: GSTM1 and GSTT1 deletions singly or together were associated with lower GST levels and higher oxidative stress in both diabetic and nondiabetic CKD. Interestingly, GSTT1 deletion appears to be associated with both diabetic and nondiabetic CKD irrespective of the GSTM1 status.

1 April 2012 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
ESEsha Sharma
Esha Sharma
MMMohammad Mustafa
Mohammad Mustafa
RPRahul Pathak
Rahul Pathak
KGKiran Guleria
Kiran Guleria
RARafat S. Ahmed
Rafat S. Ahmed
BBB.D. Banerjee
B.D. Banerjee

1 January 2018 in Gene
Verified
Journal Article
Closed access
MJMohd Jahid
Mohd Jahid
RHRehan- Ul- Haq
Rehan- Ul- Haq
DCDiwesh Chawla
Diwesh Chawla
RARajnish Avasthi
Rajnish Avasthi
RARafat Sultana Ahmed
Rafat Sultana Ahmed